221 related articles for article (PubMed ID: 15701210)
1. Treatment of the patient with diabetes: importance of maintaining target HbA(1c) levels.
Davidson JA
Curr Med Res Opin; 2004 Dec; 20(12):1919-27. PubMed ID: 15701210
[TBL] [Abstract][Full Text] [Related]
2. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007 Jun; 29(6 Pt 1):1236-53. PubMed ID: 18036387
[TBL] [Abstract][Full Text] [Related]
3. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
5. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study.
Farcasiu E; Ivanyi T; Mozejko-Pastewka B; Birkus Z; Csog J; Kowalska I; Coetzer TF; Bulgurlu S; Schinzel B; Kiljanski J
Clin Ther; 2011 Nov; 33(11):1682-93. PubMed ID: 22036246
[TBL] [Abstract][Full Text] [Related]
7. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
[TBL] [Abstract][Full Text] [Related]
8. [An update on multiple insulin injection therapy in type 1 and 2 diabetes].
Varanauskiene E; Varanauskaite I; Ceponis J
Medicina (Kaunas); 2006; 42(9):770-9. PubMed ID: 17028476
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.
Hamann A; Matthaei S; Rosak C; Silvestre L;
Diabetes Care; 2003 Jun; 26(6):1738-44. PubMed ID: 12766103
[TBL] [Abstract][Full Text] [Related]
10. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.
Murphy NP; Keane SM; Ong KK; Ford-Adams M; Edge JA; Acerini CL; Dunger DB
Diabetes Care; 2003 Mar; 26(3):799-804. PubMed ID: 12610040
[TBL] [Abstract][Full Text] [Related]
11. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
13. Challenges in optimal metabolic control of diabetes.
Liebl A
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S36-41. PubMed ID: 12324984
[TBL] [Abstract][Full Text] [Related]
14. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
Craig ME; Jones TW; Silink M; Ping YJ
J Diabetes Complications; 2007; 21(5):280-7. PubMed ID: 17825751
[TBL] [Abstract][Full Text] [Related]
15. Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design.
Levin PA; Zhang Q; Mersey JH; Lee FY; Bromberger LA; Bhushan M; Bhushan R
Clin Ther; 2011 Jul; 33(7):841-50. PubMed ID: 21719107
[TBL] [Abstract][Full Text] [Related]
16. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
Hirsch IB
Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
[TBL] [Abstract][Full Text] [Related]
17. Insulin glargine: a systematic review of a long-acting insulin analogue.
Wang F; Carabino JM; Vergara CM
Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
[TBL] [Abstract][Full Text] [Related]
18. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus.
Persson B; Swahn ML; Hjertberg R; Hanson U; Nord E; Nordlander E; Hansson LO
Diabetes Res Clin Pract; 2002 Nov; 58(2):115-21. PubMed ID: 12213353
[TBL] [Abstract][Full Text] [Related]
19. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
20. Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.
Ristic S; Bates PC
Diabetes Technol Ther; 2003; 5(1):57-66. PubMed ID: 12725708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]